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ABSTRACT

4-nonylphenol (4-NP), an endocrine-disrupting compound (EDC), has been shown to affect brain
development and may cause neurodegeneration. In the environment, 4-NP arises as a degradation
product of alkylphenol polyethoxylates, compounds widely used as nonionic surfactants in
commercial production, as well as in herbicides, pesticides, polystyrene plastics, and paints and
has been shown to undergo a high level of accumulation in biological tissues. However, the
mechanism by which 4-NP exerts its effect is not understood. Recent results from our laboratory
indicate that Gβγ, an important component of the G protein-signaling pathway, induces neuronal
outgrowth and differentiation by modulating microtubule (MT) assembly, and 4-NP interferes with
this process. 4-NP has been shown to inhibit neurotrophin-dependent neurite formation and
cellular aggregation in cultured PC12 cells. 4-NP also inhibited neurite outgrowth of Gβγoverexpressed PC12 cells. Based on these results, I hypothesize that 4-NP inhibits neurite
outgrowth and induces neurodegeneration by disrupting MTs and associated proteins through Gβγ
mediated pathway. PC12 cells were used for this study because they respond to nerve growth factor
(NGF) and exhibit a typical phenotype of neurons. In Specific Aim 1, using biochemical,
pharmacological, and immunoconfocal methodologies, I have demonstrated that 4-NP inhibited
tubulin expression, disrupted polymer-monomer equilibrium and MT organization, and inhibited
MT-Gβγ interactions in NGF-differentiated PC12 cells. In Specific Aim 2, I have conducted the
proteomic analysis of 4-NP treated cells and found that the compound affected the cytoskeletal
profile in NGF-differentiated PC12 cells. Principle Component analysis (PCA) using ScaffoldPerspective software showed that 4-NP significantly affected the protein composition/pattern of
CSK in NGF-differentiated PC12 cells. In summary, I concluded that one of the mechanisms by
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which 4-NP causes neuronal damage is by altering the Gβγ- cytoskeletal mediated pathway, which
is critical for neuronal growth and development.

v

TABLE OF CONTENTS
ACKNOWLEDGEMENTS............................................................................................................iii
ABSTRACT…………………………………………………………………….…….………..iv-v
TABLE OF CONTENTS…......................................................................................................vi-vii
LIST OF FIGURES……………………………………………………………………..……....viii
LIST OF TABLES……………………………………………………………..…….……...........ix
Chapter
1. INTRODUCTION……………………………………………………..……......................1-12
1.1.

4-Nonylphenol (4-NP)………………………………..………………….……….......1

1.2.

4-Nolylphenol (4-NP) and Neurodegeneration............................................................3

1.3.

Neuronal Cytoskeleton, Neurite Outgrowth, and Neurodegeneration..........................4

1.4.

Microtubule Assembly (MT) and G-Protein-Mediated Signaling……........................8

1.5.

Proteomic Analysis and Mass Spectrometry………………………………………..11

1.6.

Hypothesis and Specific Aims....................................................................................12

2. MATERIALS AND METHODS…………………………….....…………….………….13-18
2.1.

Cell Culture, NGF and 4-NP treatment………………...…………..………….........13

2.2.

Extraction of Cytoskeletal (CSK) and Soluble (SOL) Protein
Fractions…………………………………………………………………..…......13-14

2.3.

Preparation of Whole-cell Lysate……………......................……………………….14

2.4.

Co-immunoprecipitation (Co-IP) methodology……………………...………….14-15

2.5.

Electrophoresis and Immunoblotting..........................................................................15

2.6.

Confocal Microscopy and Immunostaining..........................................................15-16

2.7.

Statistical Analysis......................................................................................................16

2.8.

Sample Preparation for Proteomic analysis...........................................................16-17
2.8.1. LC/MS/MS analysis..................................................................................17-18
2.8.2. Protein identification......................................................................................18

3. RESULTS……………………………………………………..…...……………….….....19-46
3.1.

Specific Aim-1: Determine if 4-nonylphenol alters MTs/actin cytoskeleton through
Gβγ/GSK3β mediated pathway……..........................................................................19
3.1.1. Objective and Overview………………………………………………….....19

vi

3.1.2. 4-NP alters tubulin expression but does not alter Gβγ expression in NGFdifferentiated PC12 cells...........................................................................19-20
3.1.3. 4-NP inhibits the interaction of Gβγ with tubulin in NGF-differentiated PC12
cells ………………………………………….………………………….......22
3.1.4. 4-NP alters Polymer-monomer (MT/tubulin) equilibrium…...………..…....24
3.1.5. Confocal microscopic analysis indicates 4-NP disrupts MT and Gβγ
organization, cellular morphology and neurite formation………………......26
3.2.

Specific Aim-2: Examine the cytoskeletal alteration and neurodegeneration induced
by 4-nonylphenol.………………...……....................................................................29
3.2.1. Objective and Overview…………………………..………...…………..…..29
3.2.2. Proteomic analysis of cytoskeletal fraction reveals that 4-NP downregulated
tubulin/actin but upregulated significantly G protein subunits including β1
and β2 in NGF-differentiated PC12 cells……………………..................30-36
3.2.3. Top ten proteins most affected

by 4-NP (up- and down-regulated) in

CSK in control and NGF-differentiated PC12 cells.............................37-39
3.2.4. Principal Component Analysis..................................................................40
3.2.5. String Link and gene ontology (GO) enrichment analysis...................41-45
4. DISCUSSION……………………………………………………...………………...…..47-50
REFERENCES………………………………………………………..……..…………….....51-53
CURRICULUM VITA…………………………………………………………….....……….....54

vii

LIST OF FIGURES
Fig. 1.1. Chemical structures of nonylphenol polyethoxylate and nonylphenol…......……….......2
Fig. 2.1 Regulation of microtubule assembly and neurite outgrowth by Gβγ-mediated
pathway…………………………………………………………………………………………....6
Fig. 3.1 Neuronal Cytoskeleton……………………………………………………………...……7
Fig. 4.1 Signaling pathways involved in MT modulation and neuronal differentiation………....10
Fig. 5.1 Effect of 4-NP in the expression of Tubulin and Gβγ……………………………...…...21
Fig. 6.1. Interaction between tubulin and Gβ is affected by 4-NP treatment………………........23
Fig. 7.1. Gβ and Tubulin association with Microtubules………………………………………...25
Fig. 8.1. Effect of 4-NP on cytoskeletal organization, and association of Gβ, microtubules and
actin filaments in NGF-differentiated PC12 cells………………………………………………..27
Fig. 9.1. Effect of 4-NP post-incubation and co-incubation with NGF……………………….....28
Fig. 10.1 Heat map analysis of CSK proteins………………………………………………..…..32
Fig. 11.1. PCA analysis showing 4 clusters showing the effect of 4-NP......................................41
Fig. 12.1 String Analysis…………………….…………………………………………..………42
Fig. 13.1. String Analysis showing Alzheimer’s Disease and Dopaminergic Synapse pathways
affected by 4-NP CSK…………………………………………………………………...………44

viii

LIST OF TABLES
Table 1.1 Effect of NGF and 4-NP on the upregulation/downregulation of proteins in
Cytoskeletal Fractions (Spectral Count) of PC12 cells…..……...………………........................35
Table 2.1 Effect of NGF and 4-NP on the upregulation/downregulation of proteins in WCL
Fractions (Log 2) of PC12 cells………………………………………………….........................36
Table 3.1 Top 10 Up and down regulation of proteins after NGF or NGF + 4-NP treatments in
CSK……………..…………………...…………………………………………...…………..…..38
Table 4.1 Top 10 Up and down regulation of proteins after NGF or NGF + 4-NP treatments in
WCL……………………………….……………………………………………….................….39
Table 5.1 Biological pathways (shown by Gene Ontology) affected by upregulation of protein by
4-NP in NGF-differentiated PC12 cells……….............................................................................43
Table 6.1 Effect of NGF and 4-NP on the upregulation/downregulation of proteins in AD, PD
and HD pathways in Cytoskeletal Fractions of PC12 cells…………………………..………….45
Table 7.1 Alzheimer’s Pathway affected proteins……………………………………..………...46

ix

CHAPTER I: INTRODUCTION

1.1. 4-Nolylphenol (4-NP)
Endocrine disrupting compounds (EDC’s) have been found in foods, pesticides, industrial
chemicals, and consumer products and there are increasing concerns about the potential hazards
they pose for our health. These compounds also play a role in disturbing homeostatic control and
contribute to psychological disorders, cancer, and defects in reproductive, behavioral, and immune
functions (Safe, 2000). 4-nonylphenol (4-NP), an endocrine-disrupting compound (EDC), has
been shown to affect brain development and may cause neurodegeneration (California
Environmental Protection Agency, 2009). 4-NP is a synthetic organic chemical produced in
relatively large quantities in the U.S. and used primarily in making detergents, pesticides, plastics,
and rubber, as well as other commercial uses. Human exposure to 4-NP may occur through
ingestion of contaminated foods, drinking water, and contact with detergents. In the environment,
4-NP arises as a degradation product of alkylphenol polyethoxylates, compounds widely used as
nonionic surfactants in commercial production of industrial cleaners as well as in agricultural
pesticides, polystyrene, plastics, and paint production and has been shown to undergo a high level
of accumulation in biological tissues (U.S. Environmental Agency, 2010) (Fig. 1.1). Tissue
concentration of 4-NP has been measured in the 1-20 M range in aquatic organisms (Bevan,
2006). Human exposure to 4-NP may occur through ingestion of contaminated foods, drinking
water, and contact with detergents. Because of its potential environmental toxicity issues,
European countries have restricted or banned the use of NPEO since 1980s (Renner, 1997).
Because toxicity and risk at low concentrations have not been clearly proven, United States
allowed its use. However, the level of risk to humans and the environment posed by 4-NP is
currently under considerable debate by researchers, chemical manufacturers, and regulators.
1

[Fig. 1.1. Chemical structures of nonylphenol polyethoxylate and nonylphenol]
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1.2 4-Nolylphenol (4-NP) and Neurodegeneration.
4-NP, along with other EDCs, have been shown to induce deterioration of neural
development, decrease memory and learning capacity and spatial learning in monkey and rat
offspring born from mothers exposed to EDCs (Yoshikawa, 2005). Other studies have exhibited
that gestational 4-NP exposure produced a significant decrease in credits in learning and memory
functions of offspring rats (Xu et. al 2010). These data indicate that 4-NP exposure may have
potentially damaging effect during early neuronal development. 4-NP has been shown to induce
the death of neural stem cells suggesting that 4-NP might directly cause neurodegeneration (Kudo
et al, 2004).
Neurodegeneration is a pathological condition associated with the progressive loss of
neurons which occurs in many neurological disorders including Alzheimer’s disease, Parkinson’s
disease, and schizophrenia. However, the cause of neurodegenerative disorders is unknown and
there are currently no effective drugs available to treat the disease processes. Cytoskeletal
disruption in neurons and aggregation of proteins associated with these diseases is the hallmark of
neurodegeneration (Alonzo, 2008; Amniai, 2008; Gustav-rothenberg, 2010). Aging is the most
consistent risk factor for developing a neurodegenerative disorder, and recent evidence suggests
that environmental factors, which act as endocrine disruptors, pose a risk in the disease process.
More recently, 4-NP has been shown to inhibit neurotrophin-dependent neurite outgrowth
in cultured embryonic Xenopus spinal-cord neurons and PC12 cells. Interestingly, the effect of 4NP was not inhibited by the nuclear estrogen receptor antagonist, ICI182,780, but was inhibited
by the G protein antagonist, pertussis toxin (Bevan, 2006) suggesting a role of G protein signaling
in this process.

3

1.3 Neuronal Cytoskeleton, Neurite Outgrowth, and Neurodegeneration
Neurite outgrowth and differentiation is a complex process in which two distinct domains
emerge from the cell body: a long, thin axon that transmits signals and multiple shorter dendrites
that are specialized to receive signals (Sierra-Fonseca, 2014). When fully differentiated through
elongation of axon and dendrites, this morphology allows neurons to achieve precise connectivity
between appropriate sets of neurons, which is fundamental to the proper functioning of the nervous
system. Assembly and disassembly of the cytoskeleton is critical for axon and dendrite formation
as well as for neurite outgrowth. MTs and actin filaments are two major protein filaments that
constitute the neuronal cytoskeleton. MTs form dense parallel arrays in axons and dendrites that
are required for the growth and maintenance of these neurites (Witte and Bradke; Geraldo and
Gordon-Weeks, 2009) (Fig. 2.1). Unlike MTs, actin filaments in neurons are enriched in the
growth cone and organized into long bundles forming filamentous protrusions (filopodia) or veillike sheets of branched actin (lamellipodia) (Witte, 2008; Geraldo, 2009). Selective stabilization
of MTs also occurs during neuronal differentiation (Bulinsky and Gundersen, 1991).

During neurodegeneration, the MT assembly and proteins associated with them are
severely altered. In Alzheimer’s disease, amyloid plaques and neurofibrillary tangles (NFT)
comprise the two major neuropathologic brain alterations. NFT are formed from paired helical
filaments (PHF) consisting of tau, a microtubule-associated protein (MAP). Under normal
conditions, tau binds to MT, stabilizing neuron structure and integrity. In an AD brain, the MT
structure is disrupted, which causes tau to be hyperphosphorylated and not bind to the MTs (Fig.
3.1). Lewy bodies, which are considered cytopathological markers of Parkinson’s disease (PD),
are comprised of tubulins (subunit protein of MTs) MAP1, and MAP2 (Alonso et al., 2008; Amniai
et al., 2008; Gustav et al., 2010). However, the mechanism by which diseases are triggered and
4

then progress is not well understood. Recent results suggest that MT assembly is severely
compromised in both the AD and PD brains (Cash et al., 2003; Cartelli et al., 2010; Cartelli et al.,
2013). This could play a significant role in triggering early disease. Recently, we have found that
the interaction of Gβγ with MTs is important for nerve growth factor (NGF)-induced neuronal
differentiation of PC12 cells and that the sequestration of Gβγby GRK2i, a Gβγ-inhibitory
peptide, inhibits neurite outgrowth and affects MT organization, thus indicating the important role
of Gβγ in this process. Recent results from our laboratory indicate that Gβγ, an important
component of the G protein-signaling pathway, induces neuronal outgrowth and differentiation by
modulating microtubules (MT) assembly (Roychowdhury, 1997; Roychowdhury, 2006; Montoya,
2007; Sierra-Fonseca, 2014) (Fig. 2.1).
4-NP has been shown to inhibit neurotrophin-dependent neurite formation and cellular
aggregation in cultured PC12 cells. 4-NP also inhibited neurite outgrowth of Gβγ-overexpressed
PC12 cells and caused microtubule disruption, cellular aggregation and degeneration (Martinez J,
UTEP MS thesis, 2013).

5

[Fig. 2.1 Neuronal Cytoskeleton.
In neuronal cells, MTs are found in the axon of the cell and in the dendrites (red filaments). Actin
filaments (green) are present in the growth cone and the tips of the dendrites close to the plasma
membrane, where they play a role in maintaining cell shape. MAPs (blue dots) are found in the
axon where they participate in MT bundling.]
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[Figure 3.1 MT assembly and its possible role in neurodegeneration.
Irregular organization of the MT cytoskeleton is known to be a feature of neurodegeneration in
Alzheimer’s disease (AD) and Parkinson’s disease (PD). Since Gβγ is known to have a role in the
regulation of MT assembly, we propose that blocking the interaction of Gβγ with tubulin/MTs by
4-NP will alter MT organization in neuronal cell models and ultimately lead to neurodegeneration.]
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1.4 Microtubule (MT) Assembly and G protein-mediated signaling
G protein-mediated signaling is a major signaling pathway in neurons that consists of three
components; G protein-coupled receptors (GPCRs), G protein, and effector molecules. GPCRs
constitute the largest family of transmembrane receptors and mediate the action of extracellular
signals as diverse as light, odorants, peptide hormones, and neurotransmitters. Current models of
G proteins favor a heterotrimeric structure composed of the guanine- nucleotide binding α plus β
and γ subunits, the latter two forming a tight association under nondenaturing conditions. Agonistbound receptors activate G proteins by allowing GTP to bind to the βγ subunit of the heterotrimer.
Subsequently, activated Gα changes its association with Gβγ in a manner that allows both subunits
to contribute to the regulation of intracellular-effector molecules (Fig. 4.1). Results from our
laboratory indicate that β and γ subunits of G proteins regulate microtubule assembly in vitro
(Roychowdhury and Rasenick, 1997; Roychowdhury et al., 1999; Roychowdhury et al., 2006;
Montoya et al., 2007). While Gβ activates tubulin GTPase and inhibits microtubule assembly, Gβγ
promotes tubulin polymerization. Reconstituted heterotrimers were shown to be inactive in
promoting microtubule assembly, which suggests that G-protein activation is necessary for the
modulation of microtubules by G-protein subunits. Using the anti-mitotic agent nocodazole, it has
been demonstrated that the tubulin-Gβγ interaction is important for MT assembly in cultured PC12
and NIH3T3 cells (Montoya et al., 2007). More recently, it was found that Gβγ–MT interaction is
critical for NGF-induced neuronal differentiation of PC12 cells. Overexpression of Gβγ in PC12
cells (in the absence of NGF) induced neurite formation that is seen in NGF-differentiated cells.
Altogether, results from our laboratory suggested that the Gβγ, initiated by the activation of the G
protein-coupled receptor (GPCR), is a signal-transducing protein complex, and its interaction with

8

microtubules (MTs) is important to neuronal development, differentiation, structure, and
neurodegeneration (Figure 4.1).
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[Fig. 4.1 Regulation of microtubule assembly and neurite outgrowth by Gβγ-mediated
pathway.
G-protein signaling is initiated when the seven-transmembrane domain G-protein coupled receptor
(GPCR) is activated by an agonist. The Gαβγ Heterotrimer disassociates into Gα and Gβγ subunits,
which are then free to activate different effector molecules. Gβγ interacts with MTs and promotes
MT assembly.]
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1.5 Proteomic analysis and Mass Spectrometry
Proteomics, the large-scale analysis of proteins, has been inspired by the realization that
the final product of a gene is inherently more complex and closer to function than the gene itself
(Graves, 2002). It is impossible to explain mechanisms of disease, aging, and effects of the
environment solely by studying the genome. By studying proteins, protein post-translational
modifications can be characterized and drug targets can be identified. Also, using proteomics
protein-protein interaction can be identified making possible the discovery of the involvement of
proteins in metabolic pathways.
There are multiple methods to perform proteomics analysis but the method of choice is
mass spectrometry (MS). MS is an analytical technique that is used to identify and quantify
unknown materials within a sample by ionizing chemical species and characterize the ions by their
mass to charge ratio (m/z) and abundance. The mass spectrometer is the instrument used to perform
MS analysis. Software like Protein Discoverer by Thermofisher is used to quantify proteins
obtained from LC MS/MS. To do the statistical analysis Scaffold Proteome Software is used.

11

HYPOTHESIS AND SPECIFIC AIMS

The objective of my research is to understand the mechanism by which 4-NP, an endocrine
disrupting compound (EDC) induces neurodegeneration. Results from our laboratory have shown
the Gβγ, an important component of GPCR pathway is involved in neuronal differentiation (SierraFonseca, 2014). It was found that the interaction of Gβγ with MTs is important for nerve growth
factor (NGF)-induced neuronal differentiation of PC12 cells and that the sequestration of Gβγ by
GRK2i, a Gβγ-inhibitory peptide, disrupted MTs, inhibited neurite outgrowth and induced neurite
damage, thus indicating the important role of Gβγ in this process (Sierra-Fonseca 2014). Therefore,
I hypothesize that 4-NP inhibits neurite outgrowth and induces neurodegeneration in PC12 cell
model by disrupting MTs cytoskeleton through Gβγ mediated pathway. I plan to test the hypothesis
by focusing on the following aims in this study:

Specific Aim 1: Determine if 4-nonylphenol alters MTs cytoskeleton through Gβγ mediated
pathway.
Specific Aim 2: Examine the cytoskeletal disruption and neurodegeneration induced by 4nonylphenol by proteomic analysis.

12

CHAPTER 2: MATERIALS AND METHODS

2.1.Cell Culture, NGF and 4-NP Treatment
PC12 cells (pheochromocytoma cells derived from the adrenal gland of Rattus norvegicus) were
grown at 37 °C in 75-cm2 culture flasks in Dulbecco’s modified Eagle’s Medium (DMEM) (4.5
g/L glucose, L-glutamine, without pyruvate), supplemented with 10% bovine calf serum (BCS)
and antibiotics (100 U/mL penicillin, and 100 µg/mL streptomycin). For NGF treatment, PC12
cells were grown on 100- 150-mm plates to 70% confluence over 1–2 days, and then treated with
100 ng/ml of NGF (Sigma-Aldrich, St. Louis, MO) dissolved in complete media for 3 consecutive
days. Control cells (without NGF treatment) were also grown under the same conditions. Cells
were treated with 5µM or 10µM 4-Nonylphenol for 1 hour or overnight. A stock solution of 10
mM 4-NP was prepared in DMSO and diluted in DMEM media to a final concentration of 5 or 10
µM 4-NP and added to the cells as indicated in the figures.

2.2. Extraction of Cytoskeletal (CSK) and Soluble Protein (SOL) Fractions.
PC12 cells were grown in 100- or 150-mm plates to 70% confluence over 1–2 days and subjected
to NGF treatment as described above. The plates were used in duplicates for each condition.
Subsequently, the plates were treated with or without 4-NP for 1 hour or overnight. Cytoskeletal
(CSK) and soluble (SOL) fractions were prepared by extracting soluble proteins in an MTstabilizing buffer (MS). The stabilizing buffer contained 0.1 M PIPES, pH 6.9, 2 M glycerol, 5
mM MgCl2, 2 mM EGTA, 0.5% Triton X-100, protease inhibitor cocktail (Sigma-Aldrich), 0.1
mM GTP, and 1 mM DTT. Briefly, cells were rinsed and incubated with MS buffer (0.5–1 ml) for
~10 minutes at room temperature until cells were beginning to lyse. Subsequently, cells were
removed mechanically (using a cell scraper) and centrifuged at 10,000 × g for 10 min. The
13

supernatant constitutes the SOL fraction, and the cell pellets represent the CSK fraction.
Cytoskeletal pellets were washed and resuspended in 0.25 mL PEM (0.1 M PIPES, pH 6.9, 0.5
mM MgCl2, 1 mM EGTA) buffer, kept on ice for 15 min to depolymerize the MTs, sonicated on
ice for 1 min, and clarified by centrifugation. The protein concentration of the samples was
determined using the Bio-Rad protein assay, using bovine serum albumin (BSA) as a standard.

2.3. Preparation of Whole-cell lysate
PC12 cells were grown in 100-mm 150-mm plates to 80% confluence over 1-2 days, treated with
or without NGF. Subsequently, cells were then treated with and without 4-NP as described above.
The medium was removed and the cells were washed with PBS and then with 0.5-1 mL of lysis
buffer (10mM Tris-HCL, pH 7.9, 1.5 mM MgCl2, 0.3 M sucrose, 1mM DTT and protease inhibitor
cocktail). Cells were scraped with a cell scraper, sonicated for 1 min, followed by centrifugation
at 12,500 RPM (Eppendorf Minispin Plus) for 8 min at room temperature. Supernatants represent
whole-cell protein extracts. Protein concentrations were determined using the Bradford Assay and
samples were prepared for immunoblotting.

2.4. Co-immunoprecipitation (Co-IP) methodology
Cellular fractions were incubated with anti-Gβ-protein specific antibody (rabbit polyclonal antiGβ, Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at 4 °C, followed by the addition of 100
µL 50% protein A-sepharose (Amersham Biochemical, Piscataway, NJ), pre-equilibrated in 10
mM Tris-HCl, pH 8.0 at 4 °C, and followed by the addition of protein A-sepharose for 2 hours.
Samples were then centrifuged at 10,000 x g for 6 min and the pellets were washed with wash
buffer (25mM Tris-HCL pH 7.2, 150mM NaCl), centrifuged for 8 min at 12,000 RPM (Eppendorf
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Minispin Plus) at room temperature. The washing and centrifuging process was repeated 5 times
and then 100μL of 1X SDS Laemmli sample buffer was added and then boiled in a water bath for
5 min. The samples were centrifuged and IP fractions were subjected to immunoblotting.

2.5. Electrophoresis and Immunobloting
Samples for immunoblotting were subjected to SDS-polyacrylamide gel (10%) electrophoresis
followed by electro-transfer to a nitrocellulose membrane. The nitrocellulose membranes were
incubated in 5% non-fat dry milk in Tris Buffered Saline (TBS) (10 mM TrisHCl and 150 mM
NaCl, pH 7.4) for 1 hour at room temperature followed by overnight incubation with rabbit
polyclonal anti-Gβ, and mouse monoclonal anti-α-tubulin (from Santa Cruz Biotechnology). The
membranes were washed with 0.05% Tween 20 in TBS (TBST) and incubated with HRPconjugated secondary antibodies (anti-rabbit IgG, anti-mouse IgG from Promega (Madison, WI),
(1:1000)) in 0.01% BSA in TBST for 1 hr at room temperature. For sensitive detection,
chemilluminescence (ECL) technique (SuperSignal West Pico Chemiluminescent Substrate) was
used according to manufacturer’s (Pierce Biotechnology, Rockford, IL) instructions. Quantitative
analysis was done using LabWorks image acquisition and analysis software (UVP Laboratory
Products, Upland, CA).

2.6. Confocal Microscopy and Immunostaining
PC12 cells were allowed to attach to immunocytochemistry slides (Lab-TEK II mounted on glass
slides, VWR) or to coverslips placed in 12-wells plates and were grown overnight in DMEM with
bovine calf serum and penicillin-streptomycin as described above. They were then treated with or
without NGF, and 5 or 10µM 4-Nonylphenol for 1 hr or overnight. Cells were subsequently fixed
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with previously cooled (-20oC) 100% methanol. The cells were rinsed three times in 1% NGS
(normal goat serum) (Sigma-Aldrich) in PBS and blocked for 1 hr at room temperature in 5% NGS
in PBS. They were followed with incubation with primary antibodies in PBS with 1% NGS for 12 hours at 4 °C (mouse monoclonal anti-tubulin, and/or rabbit polyclonal anti-Gβγ). The slides
were rinsed as before and incubated for 2 hrs with secondary antibodies (Alexa Fluor 488, Alexa
Fluor 568, Alexa Fluor 405) (Molecular Probes-Invitrogen, Carlsbad, CA) in the dark to diminish
photo-bleaching effects. The slides were rinsed and mounted with ProLong Gold antifade reagent
with DAPI. High resolution, digital, fluorescent images were captured employing inverted,
confocal laser scanning microscopy (model LSM 700; Zeiss, New York), utilizing a PlanApochromat 63x/1.40 immersion-oil DIC objective and assisted with ZEN 2009 software (Zeiss,
New York, NY). Alexa Fluor 350 (blue), FITC (green), and rhodamine (red) were excited with
laser emissions at 405-, 488-, and 555-nm wavelengths, respectively.

2.7. Statistical analysis
All statistical analysis was performed using Sigma Plot 11 software. In the case of Western-blot
quantitative analysis, the differences between controls and treatments were assessed by means of
the student’s paired t-test. For comparisons between two groups, the student’s paired t-test was
employed. In all cases, a value of p < 0.05 was considered to be statistically significant.

2.8. Sample Preparation for Proteomic analysis
PC12 cells were grown on four 100-mm plates to 80% confluence over 2 days. The plates were
then treated with (3, 4, 5, & 6) or without (plates 1 and 2) NGF for two consecutive days, followed
by treatment with 10 μM 4-NP (plates 5 and 6) and NGF for an additional day. The Cytoskeletal
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(CSK) and soluble (SOL) fractions were then prepared by extracting soluble proteins in an MT stabilizing buffer (MS) (0.1 M PIPES, pH 6.9, 2 M glycerol, 5 mM MgCl2, 2 mM EGTA, 0.5%
Triton X-100, protease inhibitor cocktail (Sigma-Aldrich), 0.1 mM GTP, and 1 mM DTT). Briefly,
cells were rinsed and incubated with MS buffer (0.5–1 ml) for ~10 min at room temperature until
cells began to lyse. Subsequently, cells were removed using a cell scraper and centrifuged at 10,000
× g for 10 min. The supernatant constitutes the SOL fraction, and the cell pellet represents the CSK
fraction.

2.9. LC–MS/MS analysis
Protein pellets were re-suspended in 100 uL 0.4 M NH4HCO3 containing 8M urea and reduced
with 5 mM DTT for 30 min at 55°C. Reduced thiol groups were alkylated with 10 mM
iodoacetamide for 30 min at room temperature, and diluted 8-fold to a final concentration of 1M
urea, 50mM NH4HCO3. The samples were digested overnight at 37°C with sequencing grade
trypsin (Sigma-Aldrich). After quenching the reaction with TFA to a final concentration of 0.05%
TFA, the samples were desalted with 100mg C18 cartridges (Supelco) and dried in a vacuum
centrifuge.LC–MS/MS analyses were performed on an Ultimate 3000 RSLCnano system online
coupled to a Q-exactive (Thermo Scientific). Peptides were introduced to the analytical column
(Acclaim® PepMap RSLC, 75 μm × 15 cm, nanoViper, C18, 2 μm, 100 Å) and separated using a
90 min gradient from 5 to 40% solvent B at a flow rate of 300 nl/min (solvent A: 0.1% formic acid
5 % acetonitrile, solvent B: 0.1% FA 80% acetonitrile). The mass spectrometer was operated in a
data-dependent mode. Full scan MS spectra were acquired at a mass resolution of 70,000 (mass
range 400–1600 m/z and a target value of 1E6) in the Orbitrap analyzer. Tandem mass spectra of
the 10 most abundant peaks of a full scan MS spectrum were acquired following peptide
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fragmentation using higher-energy collisional dissociation (HCD) at a mass resolution 17,500
(target value of 2E5, NCE 28%, isolation width 4 m/z). The dynamic exclusion time was 15 s.

2.10. Protein identification
Protein quantification was performed using Proteome Discoverer 2.1 using the Rattus Norvegicus
database downloaded in FASTA format from Uniprot on April, 2017. Protein statistical analysis
was performed with Scaffold and Scaffold perspectives with 95% confidence and a minimum of
2 peptides. Log2 fold-change with ANOVA test were applied to obtain significant proteins (p <
.05) and quantify down and up regulation.
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CHAPTER 3: RESULTS

3.1 Specific Aim 1: Determine if 4-nonylphenol alters MTs and neuronal differentiation
through Gβγ mediated pathway.

3.1.1 Objective and Overview
Dynamic rearrangements of MTs are critical for growth cone motility and neurite
outgrowth. Recent results from our laboratory indicate that Gβγ, regulates neuronal outgrowth and
differentiation by modulating microtubule (MT) assembly (Sierra-Fonseca, 2014). In Specific Aim
1, I explored the role of 4-NP on the expression of tubulin and Gβγ, MT assembly, and the
interactions between Gβγ and tubulin/MTs during neuronal outgrowth and differentiation of PC12
cells.
3.1.2 4-NP alters tubulin expression but does not alter Gβγ expression in NGFdifferentiated PC12 cells.
To determine if 4-NP affects tubulin or Gβγ expression in NGF-differentiated PC12 cells,
PC12 cells were treated with NGF over the course of two to three days to allow for neuronal
differentiation followed by treatment with 4-NP as indicated in the figure (Fig. 5.1). Whole cell
lysates (WCL) were prepared as indicated in the methods. The samples were then processed for
western blotting using anti-tubulin and anti-Gβ (Fig. 5.1). This experiment was repeated a total of
three times and statistical analyses were carried out using one-way ANOVA. Controls represent
100%. Tubulin expression was significantly affected by 4-NP treatment (Fig. 5.1A) while Gβ
expression remained unaltered (Fig. 5.1B). The reduction of tubulin after 4-NP treatment is
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consistent with the idea that 4-NP inhibits neuronal differentiation by altering MTs/tubulin. The
differences in the mean values among the treatment groups (A) are greater than would be expected
by chance; there is a statistically significant difference (P = 0.028). The differences in the mean
values among the treatment groups (B) are not great enough to exclude the possibility that the
difference is due to random sampling variability (P = 0.679).
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[Fig. 5.1 Effect of 4-NP in the expression of Tubulin and Gβγ .
Effect of 4-NP on the expression of Tubulin and Gβ in NGF differentiated PC12 cells. PC12 cells
were treated with 100 ng/mL of NGF for two consecutive days to allow for differentiation.
Subsequently, cells were treated with or without 4-NP overnight or for 1hr (acute treatment).
Whole cell lysates were prepared as described in the methods. Equal amounts of proteins from
each sample were subjected to immunoblot analysis using anti-Tubulin or anti-Gβ antibody as
indicated. Protein bands were detected using the ECL-plus reagent, quantitated, and expressed as
indicated in the figure.]
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3.1.3 4-NP inhibits the interaction of Gβγ with tubulin in NGF-differentiated PC12 cells
To determine if 4-NP interferes with the interactions of Gβγ with tubulin during neuronal
differentiation, PC12 cells were treated with NGF over the course of two to three days (to allow
for neuronal differentiation) followed by treatment with 4-NP as indicated in the figure (Fig. 6.1).
Whole cell lysates (WCL) were prepared as indicated in the methods. Samples were then subjected
to co-IP using anti-Gβ or anti-tubulin antibodies followed by western blots using anti-Gβ or antitubulin antibody. The result indicates that NGF promoted the interactions of Gβγ with tubulin and
the effect was blocked by 4-NP. When immunoprecipitation was carried out using anti-tubulin
antibody followed by immunoblot analysis using anti-Gβ antibody, 4-NP was found to have a
similar effect on tubulin-Gβγ interaction. After NGF treatment, Gβ interaction with tubulin
increased similarly to the NGF treated cells in Fig. 6.1. The results shown also support that 4-NP
inhibits the Gβγ interaction with tubulin.
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IP: Gβ
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[Fig. 6.1. Interaction between tubulin and Gβ is affected by 4-NP treatment.
The PC12 cells were treated with NGF as indicated in the methods. Subsequently the cells were
treated with 5µM 4-NP. The whole cells lysates were prepared and subjected to
immunoprecipitation using anti-Gβ, and anti-tubulin antibodies followed by western blots using
anti-tubulin and anti-Gβ antibody as described in the methods. Protein bands were quantitated and
expressed percent Gβ co-immunoprecipitated with tubulin and tubulin co-immunoprecipitated
with Gβ with control representing 100%.]
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3.1.4 4-NP alters Polymer-monomer (MT/tubulin) equilibrium.
We evaluated the effect of 4-NP in PC12 cells to understand the role of 4-NP and its link
to MT assembly. To conduct the experiment, PC12 cells were treated with or without NGF as
indicated in the methods. Subsequently, cells were treated with or without 10μM 4-NP.
Cytoskeletal (CSK, enriched in MTs) and soluble protein fractions (SOL, enriched in dimeric
tubulin) were separated as indicated in the methods. MT assembly was assessed by calculating the
% of Tubulin in CSK fraction. We found that MT-assembly was increased in PC12 cells after
treatment at 10μM 4-NP (Figure 7.1). Previous studies indicated that Gβγ associates with
microtubules and this association is important for microtubule assembly (Roychowdhury and
Rasenick., 1997; Montoya et. al., 2007). Therefore we determined if Gβγ association with MTs
was altered after 4-NP treatment. We found that Gβ was associated with MTs and 4-NP did
increase the association.
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+NGF + 4-NP

+NGF

Control
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+4-NP

+NGF + 4-NP

+NGF

Control

Gβ associated with MTs (%)

[Fig. 7.1. Gβ and Tubulin association with Microtubules.
PC12 cells were treated with 4-NP at a concentration of 10μM for 24 hours. After incubation,
subcellular fractionation was performed and CSK fractions were subjected to Western blot using
anti-Gβ and anti-tubulin antibody as indicated in the methods. Protein bands were detected using
the ECL-plus reagent and quantitated. MT assembly was determined by assessing tubulin
immunoreactivity in the CSK fraction, and it is expressed as percent tubulin in CSK fraction.
The graphic shows percent Gβ and tubulin in CSK fractions. Values shown represent mean ±
standard error of two independent experiments done in duplicates. No significant change was
found.]

25

3.1.5. Confocal microscopic analysis indicates 4-NP disrupts MT and Gβγ organization,
cellular morphology and neurite formation
To determine the effect of 4-NP in MT and actin organization as well as neurite formation,
PC12 cells were treated with 100 ng/mL of NGF for two consecutive days to induce neurite
outgrowth. Subsequently, 5 µM 4-NP was added to the media and the cells were incubated
overnight as indicated in the figure legend (Fig. 8.1). The cells were then fixed and triple labeled
with monoclonal anti-tubulin (red), anti-actin (green) and polyclonal anti-Gβ (blue) antibodies,
and processed for confocal microscopy (Fig. 8.1). In control cells (in the absence of NGF), Gβγ
co-localized with MTs and actin filaments in the cell body. After NGF treatment, the majority of
the cells displayed neurite formation. Gβγ was detected in the neurites and in cell bodies, where
they co-localized with MTs and actin filaments. In the presence of 4-NP, neurite formations were
inhibited. Normal organization and localization of MTs, actin filaments, and Gβγ were altered.
The microtubules were pushed towards the membrane and the cells were rounded. MT intensity in
the cells was also reduced. Actin cytoskeleton was found to be damaged and actin
immunoreactivity was detected all over the cells including nucleus. The results clearly suggest that
4-NP has a very damaging effect on the cytoskeletal arrangement in NGF-differentiated PC12
cells. The results further suggest that interaction of Gβγ with tubulin/actin is important for integrity
of MTs/actin filaments, and 4-NP causes cytoskeletal disruption by inhibiting/altering these
interactions. At a higher concentration, 10 µM, 4-NP had more damaging effects on neurite
formation (Fig. 9.1). The cells that were treated after incubation with NGF had curly processes
and altered expression/localization of Gβ. Meanwhile, the cells that were treated with both NGF
and 10 µM 4-NP (Co-incubation), retained the straight process shape (Fig. 9.1, lower panel).
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[Fig. 8.1. Effect of 4-NP on cytoskeletal organization, and association of Gβ, microtubules
and actin filaments in NGF-differentiated PC12 cells.
PC12 cells were allowed to differentiate in the presence of NGF followed by treatment with 4-NP
for one day. Samples were processed for confocal microscopy using anti-Gβ (blue), anti-actin
(green), and anti-tubulin (red). In NGF treated cells, neurite outgrowth was observed. Colocalization between Gβ and tubulin was observed mainly in the neuronal processes in the 4-NP
treated cells. Actin was localized all over the neurite in the 4-NP treated cells as compared to the
NGF treated cells where it was mainly localized in the cytoskeleton.]

27

[Fig. 9.1. Effect of 4-NP post-incubation and co-incubation with NGF.
PC12 cells were allowed to differentiate in the presence of NGF followed by treatment with 4-NP
for one day. Samples were processed for confocal microscopy using anti-Gβ (green), and antitubulin (red). Blue represents nuclear labeling.]
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3.2 Specific Aim-2: Examine the cytoskeletal alterations and neurodegeneration induced by
4-nonylphenol.
3.2.1 Objective and Overview:
Cytoskeletal defect followed by its dysfunction, are hallmark of neurodegeneration
(McMurray CT 2000). Previous studies from our laboratory and the preliminary results from
Specific Aim-1 indicate that 4-NP inhibits neurite outgrowth from PC12 cells, alters MT and Gβγ
organization, and induces cellular aggregation and degeneration. In addition, interactions between
Gβγ and tubulin/actin were inhibited in the presence of 4-NP. These results suggest that 4-NP
might induce neurodegeneration by altering dynamic behavior of cytoskeleton.

Neuronal

cytoskeleton consisting of MTs, actin filaments, and neurofilaments and a large number of CSKassociated proteins, is highly dynamic in nature with an inherent ability to assemble and
disassemble in response to diverse signals. The identity of many of these proteins and signaling
molecules and how they network spatially within the cell to regulate cytoskeleton remodeling is
not well understood.

Therefore, to better understand the role of 4-NP in the disruption of the

cytoskeleton and neurodegeneration, in specific aim-2, I will conduct proteomic analysis of
cytoskeletal

fraction.

I

will

also

determine

whether

4-NP

alters

expression/localization/phosphorylation of tau proteins in NGF differentiated PC12 cells. Tau is a
microtubule-associated protein found only in axons and it is known to regulate MT assembly and
neurite outgrowth. Abnormal phosphorylation of tau and its aggregation is associated with several
human neurodegenerative disorders known as taupathies (Alonso, 2008; Amniai, 2008; GustavRothenberg, 2010).
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3.2.2 Proteomic analysis of cytoskeletal fraction reveals that 4-NP downregulated
tubulin/actin but upregulated significantly G protein subunits including β1 and β2 in NGFdifferentiated PC12 cells.
Proteomic Analysis by mass spectrometry provides a valuable tool to analyze the large
numbers of proteins in complex samples. Cytoskeleton (CSK) is composed of three major protein
filaments: actin filaments, microtubules and intermediate filaments. In addition, several
microtubules and actin-associated proteins, a large number of proteins including motor proteins
are also integral component of neuronal cytoskeleton. Therefore, we have conducted proteomic
analysis of CSK from control and 4-NP treated PC12 cells (both in the presence and the absence
of NGF). CSK fractions were subjected to LC-MS/MS analyses in the Orbitrap analyzer as
described in the methods. Protein identifications were performed with Scaffold-Perspective
software. As expected, many cytoskeletal proteins were identified in cytoskeletal fractions of
control PC12 and NGF-differentiated PC12 cells and many of them were up/down regulated in the
presence of 4-NP. The Heatmap analysis (Fig. 10.1) which shows up- and down-regulation of
cytoskeletal proteins compared to control PC12 cells. We found that ~ 500 proteins associated
with CSK were up/down-regulated in the presence of NGF (control vs NGF), and ~335 proteins
were up/down-regulated in the presence of 4-NP (NGF vs NGF+ 4-NP). Few of these proteins
(relevant to our study) are shown in Table 1.1. As shown in the table, several tubulin/actin isotypes
were found in the cytoskeleton fraction with a high score (high spectral count) reflecting the
abundance of these isotypes in CSK. As expected, all tubulin and actin isotypes, microtubuleassociated protein isotypes, were significantly upregulated (shown by single asterisk) in the
presence NGF. All of them were down-regulated in the presence of 4-NP as shown by spectral
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count but only few are statistically significant as shown by double asterisk. Interestingly beta 3
tubulin (Table 1.1), a neuron-specific tubulin isotype was upregulated in the presence of NGF
supporting further that NGF is inducing neuronal phenotype in PC12 cells. As shown in the Table
Several Microtubule-associated proteins were significantly up-regulated in the presence of NGF.
These proteins are known to promote and stabilize MTs and are very important for neuronal
functions. 4-NP did not significantly affect the expression level of most of these proteins. Among
the tubulin isotypes, Tubulin beta 3 isotype (neuron-specific protein) was slightly up-regulated in
the presence of 4-NP, while beta chain was slightly down-regulated. Among microtubuleassociated proteins (MAPs), most MAPs (MAP2, MAP1A and 1B) were not affected by 4-NP.
Interestingly, MAP 4, which was not significantly affected by NGF was up-regulated in the
presence of 4-NP (Table 1.1).
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[Fig. 10.1 Heat map analysis of CSK proteins.
The Heatmap analysis shows up- and down-regulation of cytoskeletal proteins compared to
control PC12 cells. We found that ~ 500 proteins associated with CSK were up/down-regulated
in the presence of NGF (control vs NGF), and ~335 proteins were up/down-regulated in the
presence of 4-NP (NGF vs NGF+ 4-NP).]
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Regarding G protein subunits, Gβ1 and Gβ2 were consistently associated with CSK
fractions in PC12 cells (control and NGF-differentiated) and significantly up-regulated in the
presence 4-NP (Table 1.1). This is an interesting observation because 4-NP was shown to inhibit
neurite outgrowth, induce cellular aggregation and degeneration in Gβγ overexpressed PC12 cells
(Martinez, UTEP-MS thesis 2013). Therefore, it is likely that upregulation of Gβ observed in the
presence of 4-NP might have played an important role in cytoskeletal disruption and neuronal
damage observed in 4-NP-exposed cells. Interestingly, both heavy and light chain of kinesin (a
motor protein) and actin-related protein 2/3 were differentially regulated by NGF/4-NP. We also
determined the effect of 4-NP in CSK of control PC12 cells, and found that several isotypes of
tubulin (beta 5, beta chain, alpha 1C) were (Log2 fold change ~0.28) upregulated in the presence
of 4-NP. Among the MAPs, MAP4 was significantly upregulated (Log2 fold 1.37) in the presence
of 4-NP. Interestingly, no changes in G protein subunits, 1 and 2 subunits were observed in the
CSK fraction in the presence of 4-NP.
We also carried out proteomic analysis of whole cell lysates (WCL) preparations from
control, NGF differentiated and 4-NP treated cell (Table 2.1). Table shows the cytoskeletal
proteins, and G protein subunits that are significantly up- or down-regulated in WCL. We found
that most of the tubulin isotypes that were up-regulated in CSK in response to NGF were also
increased in WCL. However, unlike CSK where several MAPs were up-regulated, only MAP1B
was upregulated in WCL. Most surprisingly, all G protein subunits were significantly downregulated in the presence NGF in WCL. We found that unlike CSK fractions, 4-NP did not have
any significant effects on the expression of these proteins in WCL. Only protein that was affected
by 4-NP was MAP4. However, 4-NP significantly down-regulated many proteins including several
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G protein subunits. Therefore, it appears that despite down-regulation of G protein subunits in
WCL, these subunits were up-regulated in CSK.
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TABLE 1.1 Effect of NGF and 4-NP on the upregulation/downregulation of proteins in
Cytoskeletal Fractions (Spectral Count) of PC12 cells

PROTEIN ID

M.Wt Accession
(kDa) Number

CON

+NGF

+NGF
+ 4-NP

Log2
Fold

Fold
Change

Actin, cytoplasmic
Actin

42
50

4265
4248

6246*
6220*

4793
4767

0.187*
0.186*

1.14
1.14

Actin, alpha skeletal

42

ACTB_
AOAOG2K3
K2
ACTS

1129

2057*

1316**

Tubulin beta-5 chain
Tubulin beta chain
Tubulin beta-4B chain
Tubulin alpha-1C chain
Filamin A
Guanine nucleotidebinding protein subunit
beta-2
Guanine nucleotidebinding protein subunit
beta-1
Guanine nucleotidebinding protein G(i)
subunit alpha-2
Guanine nucleotidebinding protein G(o)
subunit alpha
Guanine nucleotidebinding protein G(k)
subunit alpha
Kinesin-1 heavy chain

50
50
50
50
280
37

TBB5

3849*
1557*
2995*
2683*
1868
72

3456
1445
2740
2232
1306
103**

1.47
0.63
1.4
1.50
1.53
1.47

GBB2

2097
853
1575
1408
1120
58

0.551*
-0.661**
0.478*
0.564*
0.615*
0.551*
0.62 **

1.53

37

GBB1

45

56

89**

0.812**

1.76

41

GNA12

11

27

37

40

GNA0

3

6

10

41

GNAI3

1

3

13**

2.18**

4.53

110

KINH

18

5

22**

2.24**

4.72

1

17*

10

3.76*

13.5

4

22*

20

2.13*

4.38

11

34

53**

0.799**

1.71

111

64*

78

-1.18*

0.44

TBB4B
TBA1C

Microtubule-associated
300
MAP1A
protein 1A
Microtubule-associated
270
F1LRL9
protein 1B
Microtubule-associated
110
MAP4
protein 4
Actin-related protein 2/3 42
ARC1A
complex subunit 1A
* Control vs NGF
** NGF vs NGF+4-NP
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TABLE 2.1 Effect of NGF and 4-NP on the upregulation/downregulation of proteins in
WCL Fractions (Log 2) of PC12 cells

PROTEIN ID

Accession
Number

WCL
Control vs NGF

Actin, cytoplasmic 1
Actin
Actin, alpha skeletal
Tubulin beta-5 chain
Tubulin beta chain
Tubulin beta-4B chain
Tubulin alpha-1C chain
Filamin A
Guanine nucleotidebinding protein subunit
beta-2
Guanine nucleotidebinding protein subunit
beta-1
Guanine nucleotidebinding protein G(i)
subunit alpha-2
Guanine nucleotidebinding protein G(o)
subunit alpha
Guanine nucleotidebinding protein G(k)
subunit alpha
Kinesin-1 heavy chain
Microtubule-associated
protein 1A
Microtubule-associated
protein 1B
Microtubule-associated
protein 4
Actin-related protein 2/3
complex subunit 1A

NGF vs NGF
+ 4-NP

Control vs 4-NP

ACTB_
AOAOG2K3
K2
ACTS
TBB5
G3V7C6
TBB4B
TBA1C
C0JPT7
GBB2

0.331
0.331

-0.44
-0.44

GBB1

-0.459

-0.721

GNA12

-1.31

-1.91

GNA0

-1.41

-1.72

0.563
0.51
0.865
-0.654
-0.697

GNAI3

-2.12

KINH
MAP1A
F1LRL9

1.06

MAP4
ARC1A

-1.68
0.711

-2.18
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-0.979

3.2.3. Top ten proteins most affected by 4-NP (up- and down-regulated) in CSK in control
and NGF-differentiated PC12 cells
To understand the mechanisms by which 4-NP alters CSK, we identified most affected
proteins (up or down-regulated) from proteomic analysis. Top ten up and down regulated proteins
in the CSK fraction are shown in Table 3.1. These affected proteins include Cbr1 (NADPH),
MAP1a, Huntington Interacting protein 1, and Mitochondrial ribosomal protein L13. The gene
Cbr1 encodes for carbonyl reductase 1 which according to several studies suggest that CBR1
represents a significant pathway for the detoxification of reactive aldehydes derived from lipid
peroxidation and that CBR1 in humans is essential for neuronal cell survival and to confer
protection against oxidative stress-induced brain degeneration (Rashid, 2016). Interestingly, this
gene is downregulated in NGF treated cells but is upregulated in NGF treated cells that were
subsequently treated with 4-NP. The MAP1a gene encodes for a protein that is believed to be
involved in microtubule assembly. Previous studies have indicated that disruption of MAP1a could
be a very early manifestation of Aβ-mediated synaptic dysfunction—one that presages the clinical
onset of AD by years (Clemmensen, 2012). This gene is shown to be upregulated in NGF treated
cells by 3.76 log2 fold. Although neurodegenerative diseases exhibit distinct pathological features,
abnormal endocytic trafficking is apparent in several neurodegenerative diseases, such as
Alzheimer’s disease, and Parkinson’s disease (Wang et al., 2014). Huntington interacting protein
1 has been shown to be involved in clathrin-mediated endocytic trafficking and is downregulated
in the presence of 4-NP.
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TABLE 3.1 Top 10 Up and down regulation of proteins after NGF or NGF + 4-NP
treatments in CSK
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TABLE 4.1 Top 10 Up and down regulation of proteins after NGF or NGF + 4-NP
treatments in WCL
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3.2.4. Principal Component Analysis
We also carried out Principal component analysis (PCA) using scaffold-perspective software to
successfully separate out 4 clusters corresponding to different treatment conditions as shown in
Fig. 11.1. It is clear from the figure that NGF-induced neuronal differentiation of PC12 cells has
profound effect on altering protein profile of cytoskeleton of PC12 cells. However, it is also clear
that 4-NP has significantly affected the protein composition/pattern of CSK in NGF-differentiated
PC12 cells.

Fig. 11.1. PCA analysis showing 4 clusters showing the effect of 4-NP
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3.2.5. String Link and gene ontology (GO) enrichment analysis
Scaffold Perspective software was also used to carry out gene ontology (GO) enrichment analysis.
This analysis helps in identifying protein that are upregulated or downregulated under certain
condition (or treatment), are associated with specific biological functions, i.e. to assess biological
meaning with gene ontology. Fig. 12.1 shows that the several biological pathways are affected by
upregulation of proteins by 4-NP in NGF differentiated PC12 cells. Some of the pathways that are
relevant to cytoskeleton are shown in Table 5.1. Interestingly, KEGG pathway (Kyoto
Encyclopedia of Genes and Genomes) shows Alzheimer’s, Parkinson’s, and Huntington disease
pathways are affected by 4-NP treatment. KEGG is a collection of manually drawn pathway
generated from large-scale molecular datasets generated by omic analysis. Two pathways,
Alzheimer’s Disease and Dopaminergic synapse pathways, from the KEGG pathway previously
mentioned in Table 5.1, were affected by 4-NP treatment and are shown in Fig. 13.1. Several genes
from these pathways are listed in Table 6.1. Several proteins of the succinate dehydrogenase
subtypes, NADH subtypes, and ATP synthase subtypes, are affected by 4-Nonylphenol treatment
and are found in various neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and
Huntington’s. However, some proteins, such as Guanine nucleotide-binding protein G(k) subunit
alpha and Calpain-2 catalytic subunit, are pathway specific (Table 6.1). The CSK proteins that
were affected in control PC12 cells after 4-NP treatment are NADH dehydrogenase subtypes,
succinate dehydrogenase subtypes, along with cytochrome c oxidase subtypes (Table 7.1). These
proteins are known to be crucial to the survival and function of neural cells. The malfunction of
mitochondria including cytochrome c oxidase, the terminal enzyme complex of the respiratory
chain, increases ATP levels in neural cells and subsequently increases the production of reactive
oxygen species (Arnold, 2012).
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Fig. 12.1 String Analysis
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Table 5.1 Biological pathways (shown by Gene Ontology) affected by upregulation of
protein by 4-NP in NGF-differentiated PC12 cells.
Pathway ID

GO: 0008092
GO: 0044444
GO: 0005737
GO: 0005856
GO: 0044430
GO: 0015630
GO: 0005874
0512-KEGG pathway
0516-KEGG pathway
0510-KEGG pathway
04728: KEGG pathway

Pathway description

cytoskeletal protein binding
cytoplasmic part
cytoplasm
cytoskeleton
cytoskeletal part
Microtubule cytoskeleton
microtubule
Parkinson’s disease
Huntington’s disease
Alzheimer’s disease
Dopaminergic synapse

43

Count in
gene
set
9
70
82
17
12
10
6
14
14
13
5

Alzheimer’s
Disease

Dopaminergic
Synapse
[Fig. 13.1. String Analysis showing Alzheimer’s Disease and Dopaminergic Synapse
pathways affected by 4-NP in CSK.
String link shows that several genes encoding for proteins involved in Alzheimer’s disease, and
Dopaminergic synapse are affected by 4-NP treatment.]
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TABLE 6.1: Effect of NGF and 4-NP on the upregulation/downregulation of proteins in
AD, PD and HD pathways in Cytoskeletal Fractions of PC12 cells

PROTEIN ID

M.Wt
(kDa)

Accession
Number

CON

+NGF

+NGF
+ 4-NP

Log2 Fold

Pathways

Succinate dehydrogenase
[ubiquinone] flavoprotein
subunit
Succinate dehydrogenase
[ubiquinone] iron-sulfur subunit
NADH-ubiquinone
oxidoreductase 7
NADH dehydrogenase
(Ubiquinone) flavoprotein 1
Cytochrome b-c1 complex
subunit 1
Cytochrome b-c1 complex
subunit 2
ATP synthase subunit gamma

72

SDHA_RAT

-

46

90

0.97**

AD, PD,
HD

32

SDHB_RAT

-

21

36

0.78**

AD, PD, HD

79

NDUS1_RAT

-

212

226

0.092**

AD, PD, HD

51

Q5XIH3_RAT

104

63

115

AD, PD, HD

53

QCR1_RAT

-

168

201

-1.05*
0.87**
0.26**

48

QCR2_RAT

-

111

132

0.25**

AD, PD, HD

33

Q6PCU0_RAT

64

54

94

AD, PD, HD

ATP synthase subunit alpha

60

ATPA_RAT

-

591

643

ATP synthase subunit beta

56

G3V6D3_RAT

767

810

910

ATP synthase subunit O

23

ATPO_RAT

47

35

75

115

AT2A2_RAT

-

10

26

-0.57*
0.78**
-0.24*
0.12**
-0.24*
0.17**
-0.75*
1.1**
0.23**

80

CAN2_RAT

-

25

36

AD

ADP/ATP translocase 2

33

ADT2_RAT

-

131

157

-1.21*
0.53**
0.23**

Protein DJ-1

20

PARK7_RAT

41

22

38

PD

Guanine nucleotide-binding
protein G(k) subunit alpha
DNA-directed RNA
polymerase II subunit RPB7
Polymerase (RNA) II (DNA
directed) polypeptide D
(Predicted)

41

GNAI3_RAT

-

3

13

-1.23*
0.79**
2.07**

19

RPB7_RAT

33

23

34

0.56**

HD

16

D4A259_RAT

-

21

32

0.61**

HD

Sarcoplasmic/endoplasmic
reticulum calcium ATPase 2
Calpain-2 catalytic subunit

* Control vs NGF

** NGF vs NGF+4-NP
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AD, PD, HD

AD, PD, HD
AD, PD, HD
AD, PD, HD
AD

PD, HD

PD

Table 7.1 Alzheimer’s Pathway affected proteins
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CHAPTER 4: DISCUSSION

Because the U.S population is growing older, and aging is the most consistent risk factor of
developing a neurodegenerative disorder, neurodegenerative diseases are expected to surge in the
coming years. Since the pathogenesis of many of these diseases is unknown, the role of
environmental factors must be considered. Until recently, the major concerns of environmental
factors on human health were centered on potential roles in cancer. However, attention is now
focused on understanding the damaging role of environmental factors on developing and mature
nervous systems. Recent evidence suggests that environmental chemicals that act as endocrine
disruptors (EDC) may adversely affect brain development and induce neurodegeneration. The
results presented in this study demonstrate that 4-Nolylphenol (4-NP), an EDC, inhibits NGFinduced neuronal differentiation of PC12 cells by altering MT-Gβγ association. Dynamic
rearrangement of microtubules (MTs) is critical for growth-cone motility and neurite outgrowth.
Previously, Gβγ has been shown to play a key role in this process by stimulating MT assembly
required for neurite outgrowth. This was further supported by the fact that blocking Gβγ-MT
interaction by a Gβγ-sequestering peptide, GRK2i, inhibited neurite outgrowth and induced
neurodegeneration (Sierra Fonseca et. al., 2014). The observation that 4-NP alters MT organization
and its association with Gβγ suggests that 4-NP induces neurodegeneration by affecting the GβγMT mediated pathway.
Proteomic analysis of cytoskeletal fraction (CSK) of 4-NP-treated PC12 cells (both control
PC12 and NGF-differentiated cells) produced many interesting results. Because of the insoluble
nature of CSK fraction, little attempt was made in the past to carry out proteomic analysis of this
cellular structure. However, recently, while this study was in progress, a group of investigators
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claimed to enrich CSK fraction from mouse embryonic fibroblasts for proteomic analysis (Choi
et.al., 2013; Klemke et. al., 2013). Although this analysis indicated that actin cytoskeleton and
focal adhesion-associated proteins were preserved in CSK preparation, microtubule cytoskeleton
was disrupted during the purification steps used by these investigators. Our result indicates that
MTs and other cytoskeletal proteins were preserved in CSK fraction isolated using our protocol.
In addition, heterotrimeric G protein subunits were found to be associated with cytoskeletal
fractions. This finding supports the core hypothesis of our laboratory research—that Gβγ is an
integral component of cell cytoskeleton. The result also suggests that NGF-induced neuronal
differentiation involves up- or down-regulation of these proteins.
We found that all tubulin, actin, and microtubule-associated protein isotypes, were
significantly upregulated in the presence NGF in CSK. Among the tubulin isotypes, Tubulin beta
3 isotype (neuron-specific protein) was slightly up-regulated in the presence of 4-NP, while beta
chain was slightly down-regulated (Table 1.1). Regarding G protein subunits, Gβ1 and Gβ2 were
consistently associated with CSK fractions in PC12 cells (control and NGF-differentiated) and
significantly up-regulated in the presence 4-NP (Table 1.1). This is an interesting observation.
Although Gassociation with MTs was shown to be important for MT assembly, and
overexpression of G promotes neurite outgrowth (Sierra-Fonseca 2014, 2017), 4-NP was shown
to inhibit neurite outgrowth, induce cellular degeneration and damage in NGF differentiated and
G-overexpressed cells. Thus, it appears that adequate expression level of G is critical for
neuronal differentiation and morphology. In fact, although overexpression of G induced
neuronal differentiation, many of the G overexpressed cells had altered morphology (SierraFonseca et.al 2014). Therefore, it is likely that upregulation of Gβ observed in the presence of 4-
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NP might have played an important role in cytoskeletal disruption and neuronal damage observed
in 4-NP-exposed cells.
We found that most of the tubulin isotypes that were up-regulated in CSK in response to
NGF were also increased in WCL (Table 2.1). However, unlike CSK where several MAPs were
up-regulated, only MAP1B was upregulated in WCL. Most surprisingly, all G protein subunits
were significantly down-regulated in the presence NGF in WCL, and unlike CSK fractions, 4-NP
did not have any significant effects on the expression of these proteins in WCL. Only protein that
was affected by 4-NP was MAP4. Several genes, CBR1, MAP1a, Huntington Interacting protein
1, are apparent in several neurodegenerative diseases, such as Alzheimer’s disease, Huntington’s,
and Parkinson’s disease. Interestingly, these genes are affected after NGF and/or after 4-NP
treatment.
String Link and gene ontology (GO) enrichment analysis indicated that many proteins in
AD, PD, and HD pathways were affected by NGF (Table 6.1). While many of these proteins were
downregulated in the presence of NGF, they were significantly upregulated after treatment with 4NP.

The results clearly suggest that 4-NP inhibits neuronal differentiation, and promotes

neurodegenerative processes by upregulating the proteins involved in AD, PD and HD pathways.
Future experiments will be designed to understand the role of these proteins in CSK disruption and
neurodegeneration.
In summary, I have demonstrated that 4-NP at concentrations (5-10µM, ~10002000µg/L) was potent in inducing cellular aggregation and neurodegeneration. Previous studies
indicated that 4-NP at a concentration as low as 0.2µM (44.07 µg/L) affected neurite outgrowth
(Martinez, UTEP MS thesis 2013). Most NP-effect is associated with water concentration
ranging from 1 to 1000µg/L (California Environmental Protection Agency, 2009).
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Concentrations of 4-nonylphenol in surface waters are in the range of 0.11 to 180 µg/L (Tanghe
and Verstraete, 2001). However, this concentration may not reflect 4-NP exposure in the
environment, based on 4-NP’s low solubility and hydrophobicity, and higher concentrations
often detected in Biosolid and sediment samples. Using PC12 cells as a model system, our study
clearly demonstrates the potential risk of 4-NP in affecting neuronal development and inducing
neurodegeneration, and should provide essential information in accessing environment risk of 4NP.
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